|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10045 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-OLFM4 |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human OLFM4 |
中文名稱 抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用
英文名稱 Anti-OLFM4
別 名 Antiapoptotic protein GW112; G-CSF-stimulated clone 1 protein; GC1; GW112; hGC 1; hGC-1; hOLfD; olfactomedin 4; Olfactomedin-4; OlfD; OLFM4; OLFM4_HUMAN; OLM4.
產(chǎn)品屬性：
抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用 濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物標(biāo)志物
蛋白分子量 predicted molecular weight: 55kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human OLFM4
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Olfactomedin-4, also known as G-CSF-stimulated clone 1 protein, Antiapoptotic protein GW112, and OLFM4, is a secreted protein which contains one olfactomedin-like domain. OLFM4 is expressed during myeloid lineage development. It is strongly expressed in the prostate, small intestine and colon and moderately expressed in the bone marrow and stomach. OLFM4 is highly expressed in pancreatic cancer tissues and shows an elevated expression level during the early S phase of the cell cycle. It is also expressed at high levels in stomach cancer and colon cancer tissues. Inhibition of ROS or the ERK pathway remarkably decreased G-CSF-induced OLFM4 expression. OLFM4 is an antiapoptotic factor that promotes tumor growth. OLFM4 promotes proliferation of pancreatic cancer cells by favoring the transition from the S to G2/M phase. OLFM4 also facilitates cell adhesion. Induction of OLFM4 in cancer cells was reported to have a novel antiapoptotic action via binding to the potent apoptosis inducer GRIM-19. The human OLFM4 is also thought to be a useful marker for early myeloid development.
Function : May promote proliferation of pancreatic cancer cells by favoring the transition from the S to G2/M phase. In myeloid leukemic cell lines, inhibits cell growth and induces cell differentiation and apoptosis. May play a role in the inhibition of EIF4EBP1 phosphorylation/deactivation. Facilitates cell adhesion, most probably through interaction with cell surface lectins and cadherin.
Subunit : Homomultimer; disulfide-linked. Interacts with NDUFA13. Interacts with cell surface lectins (locutions ricinus communis agglutinin I, concanavalin-A and wheat germ agglutinin) and cadherin.
Subcellular Location : Secreted, extracellular space. Mitochondrion. Note=Subcellular location is not clearly defined: has been shown to be secreted (PubMed:16566923), but also in the mitochondrion (PubMed:15059901 and PubMed:20724538), cytoplasm and plasma membrane (PubMed:20724538) and in the nucleus (PubMed:15059901).
Tissue Specificity : Expressed during myeloid lineage development. Much higher expression in bone marrow neutrophils than in peripheral blood neutrophils (at protein level). Strongly expressed in the prostate, small intestine and colon and moderately expressed in the bone marrow and stomach. Overexpressed in some pancreatic cancer tissues.
Post-translational modifications : N-glycosylated.
Similarity : Contains 1 olfactomedin-like domain.
Database links : UniProtKB/Swiss-Prot: Q6UX06.1
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品：
HD(Human Histone Deacetylase) ELISA Kit 人組織蛋白去乙?；窶ulti-class antibodies規(guī)格： 48T
Anti-NTCP 離子/磺膽酸共轉(zhuǎn)運(yùn)蛋白Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh IFNA4/IFNA76/IFNA M1 干擾素α4抗體 規(guī)格 0.2ml
t-PA ELISA Kit 大鼠組織型纖溶酶原激活劑 96T
PGC1 beta 英文名稱： 過氧化物酶體增殖物激活受體γ輔激活子1β抗體 0.2ml
CD239 英文名稱： B細(xì)胞粘附分子CD239抗體 0.2ml
Anti-NTCP 離子/磺膽酸共轉(zhuǎn)運(yùn)蛋白Multi-class antibodies規(guī)格： 0.2ml
TRIM32(tripartite motif protein 32) TRIM32抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-CAP1 CAP1抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh PDE4D 磷酸二酯酶4D抗體 規(guī)格 0.1ml
Actin, Muscle Specific 濃縮液 0.1ml 進(jìn)口分裝
TNFAIP3 interacting protein 3 英文名稱： 壞死因子α誘導(dǎo)相互作用蛋白3抗體 0.2ml
phospho-CREB-1(Ser133) 英文名稱： 磷酸化CREB-1抗體 0.1ml
Anti-CAP1 CAP1抗體Multi-class antibodies規(guī)格： 0.2ml
IGF-1 ELISA Kit 大鼠樣生長因子1Multi-class antibodies規(guī)格： 48T
Anti-BAFFR/Tnfrsf13c/CD268/FITC 熒光素標(biāo)記B細(xì)胞活化因子受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh ET-1(2C4) 內(nèi)皮素-1單克隆抗體 規(guī)格 0.2ml
sCKR(Human soluble cytokine receptor) ELISA Kit 人可溶性細(xì)胞因子受體 96T
MSK1 英文名稱： 有絲分裂原和應(yīng)激活化型蛋白激酶1抗體 0.2ml
Annexin A2 英文名稱： 膜粘連蛋白 Ⅱ抗體 0.1ml
Anti-BAFFR/Tnfrsf13c/CD268/FITC 熒光素標(biāo)記B細(xì)胞活化因子受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml
TNFSF13B Protein Human 重組人 BLyS / TNFSF13B / BAFF 蛋白 (Fc 標(biāo)簽)
HEL(懸浮) 紅白細(xì)胞細(xì)胞
ST6GAL1 Others Mouse 小鼠 ST6GAL1 / CD75 人細(xì)胞裂解液 (陽性對(duì)照)
HEC-1-A人子宮內(nèi)膜腺癌細(xì)胞 HEC-1-A human endomeial adenocarcinoma cells McCOY's 5A+10%FBS
人胚;WI-38 [WI38]
大鼠海馬趾神經(jīng)細(xì)胞(RHh)(1×106) WM451, 人細(xì)胞 Human
CL-0396NCI-H226(人肺鱗癌細(xì)胞)5×106cells/瓶×2
CFR Others Human 人 CFR / CFR-alpha 桿狀病毒-昆蟲細(xì)胞裂解液 (陽性對(duì)照)
人脈絡(luò)叢上皮細(xì)胞RNAHCPEpiC miRNA5 μg
6T-CEM細(xì)胞，T細(xì)胞 人巨細(xì)胞性細(xì)胞,801-D細(xì)胞 細(xì)胞
貓腎細(xì)胞;CRFK
ADAM15 Others Human 人 ADAM15 / MDC15 人細(xì)胞裂解液 (陽性對(duì)照)
抗細(xì)胞凋亡蛋白OLFM44抗體費(fèi)用 TNFSF13B Protein Human 重組人 BLyS / TNFSF13B / BAFF 蛋白 (Fc 標(biāo)簽)
HEL(懸浮) 紅白細(xì)胞細(xì)胞
ST6GAL1 Others Mouse 小鼠 ST6GAL1 / CD75 人細(xì)胞裂解液 (陽性對(duì)照)
HEC-1-A人子宮內(nèi)膜腺癌細(xì)胞 HEC-1-A human endomeial adenocarcinoma cells McCOY's 5A+10%FBS
人胚;WI-38 [WI38]
大鼠海馬趾神經(jīng)細(xì)胞(RHh)(1×106) WM451, 人細(xì)胞 Human
|
|
|
|
